Cargando…

Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?

PURPOSE: To provide current knowledge on respiratory virus-induced heterologous immunity (HI) with a focus on humoral and cellular cross-reactivity. Adaptive heterologous immune responses have broad implications on infection, autoimmunity, allergy and transplant immunology. A better understanding of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pusch, Emanuel, Renz, Harald, Skevaki, Chrysanthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100437/
https://www.ncbi.nlm.nih.gov/pubmed/32226720
http://dx.doi.org/10.1007/s40629-018-0056-0
_version_ 1783511440960782336
author Pusch, Emanuel
Renz, Harald
Skevaki, Chrysanthi
author_facet Pusch, Emanuel
Renz, Harald
Skevaki, Chrysanthi
author_sort Pusch, Emanuel
collection PubMed
description PURPOSE: To provide current knowledge on respiratory virus-induced heterologous immunity (HI) with a focus on humoral and cellular cross-reactivity. Adaptive heterologous immune responses have broad implications on infection, autoimmunity, allergy and transplant immunology. A better understanding of the mechanisms involved might ultimately open up possibilities for disease prevention, for example by vaccination. METHODS: A structured literature search was performed using Medline and PubMed to provide an overview of the current knowledge on respiratory-virus induced adaptive HI. RESULTS: In HI the immune response towards one antigen results in an alteration of the immune response towards a second antigen. We provide an overview of respiratory virus-induced HI, including viruses such as respiratory syncytial virus (RSV), rhinovirus (RV), coronavirus (CoV) and influenza virus (IV). We discuss T cell receptor (TCR) and humoral cross-reactivity as mechanisms of HI involving those respiratory viruses. Topics covered include HI between respiratory viruses as well as between respiratory viruses and other pathogens. Newly developed vaccines which have the potential to provide protection against multiple virus strains are also discussed. Furthermore, respiratory viruses have been implicated in the development of autoimmune diseases, such as narcolepsy, Guillain–Barré syndrome, type 1 diabetes or myocarditis. Finally, we discuss the role of respiratory viruses in asthma and the hygiene hypothesis, and review our recent findings on HI between IV and allergens, which leads to protection from experimental asthma. CONCLUSION: Respiratory-virus induced HI may have protective but also detrimental effects on the host. Respiratory viral infections contribute to asthma or autoimmune disease development, but on the other hand, a lack of microbial encounter is associated with an increasing number of allergic as well as autoimmune diseases. Future research might help identify the elements which determine a protective or detrimental outcome in HI-based mechanisms.
format Online
Article
Text
id pubmed-7100437
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-71004372020-03-27 Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Pusch, Emanuel Renz, Harald Skevaki, Chrysanthi Allergo J Int Review PURPOSE: To provide current knowledge on respiratory virus-induced heterologous immunity (HI) with a focus on humoral and cellular cross-reactivity. Adaptive heterologous immune responses have broad implications on infection, autoimmunity, allergy and transplant immunology. A better understanding of the mechanisms involved might ultimately open up possibilities for disease prevention, for example by vaccination. METHODS: A structured literature search was performed using Medline and PubMed to provide an overview of the current knowledge on respiratory-virus induced adaptive HI. RESULTS: In HI the immune response towards one antigen results in an alteration of the immune response towards a second antigen. We provide an overview of respiratory virus-induced HI, including viruses such as respiratory syncytial virus (RSV), rhinovirus (RV), coronavirus (CoV) and influenza virus (IV). We discuss T cell receptor (TCR) and humoral cross-reactivity as mechanisms of HI involving those respiratory viruses. Topics covered include HI between respiratory viruses as well as between respiratory viruses and other pathogens. Newly developed vaccines which have the potential to provide protection against multiple virus strains are also discussed. Furthermore, respiratory viruses have been implicated in the development of autoimmune diseases, such as narcolepsy, Guillain–Barré syndrome, type 1 diabetes or myocarditis. Finally, we discuss the role of respiratory viruses in asthma and the hygiene hypothesis, and review our recent findings on HI between IV and allergens, which leads to protection from experimental asthma. CONCLUSION: Respiratory-virus induced HI may have protective but also detrimental effects on the host. Respiratory viral infections contribute to asthma or autoimmune disease development, but on the other hand, a lack of microbial encounter is associated with an increasing number of allergic as well as autoimmune diseases. Future research might help identify the elements which determine a protective or detrimental outcome in HI-based mechanisms. Springer Medizin 2018-03-26 2018 /pmc/articles/PMC7100437/ /pubmed/32226720 http://dx.doi.org/10.1007/s40629-018-0056-0 Text en © Springer Medizin Verlag GmbH, a part of Springer Nature 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Pusch, Emanuel
Renz, Harald
Skevaki, Chrysanthi
Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
title Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
title_full Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
title_fullStr Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
title_full_unstemmed Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
title_short Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
title_sort respiratory virus-induced heterologous immunity: part of the problem or part of the solution?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100437/
https://www.ncbi.nlm.nih.gov/pubmed/32226720
http://dx.doi.org/10.1007/s40629-018-0056-0
work_keys_str_mv AT puschemanuel respiratoryvirusinducedheterologousimmunitypartoftheproblemorpartofthesolution
AT renzharald respiratoryvirusinducedheterologousimmunitypartoftheproblemorpartofthesolution
AT skevakichrysanthi respiratoryvirusinducedheterologousimmunitypartoftheproblemorpartofthesolution